A Temporary Win for Colorectal Cancer Research and Screening – Fight Colorectal Cancer
A Temporary Win for Colorectal Cancer Research and Screening – Fight Colorectal Cancer Oncodaily
Онкология
Колоректальный рак
210 материалов по теме, собраны автоматически из проверенных источников
🎗️
Онкология
Colorectal Cancer Pipeline Appears Robust With 195+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Colorectal Cancer Pipeline Appears Robust With 195+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight Barchart.com
Онкология
Fecal microbial signatures show promise for colorectal and pancreatic cancer assessment
Gastrointestinal and pancreatobiliary cancers can be difficult to detect early, creating a need for practical, noninvasive approaches for early detection and risk assessment. The gut microbiome has emerged as a potential source of cancer biomarkers, offering practical opportunities for noninvasive testing, as…
Онкология
ctDNA Predicts Colon Cancer Recurrence, but Treatment Questions Remain
ctDNA Predicts Colon Cancer Recurrence, but Treatment Questions Remain The American College of Surgeons
Онкология
MRD Across Breast and Colorectal Cancer: What Clinicians Can Learn From ctDNA | Biomarker Navigator
MRD Across Breast and Colorectal Cancer: What Clinicians Can Learn From ctDNA | Biomarker Navigator DocWireNews
Онкология
Closing the colorectal screening gap starts with matching options to patient preference
Clinicians have more colorectal cancer screening options than ever before. The challenge is helping more eligible patients complete them. Colorectal cancer screening has the power to change patient outcomes by detecting disease earlier and, in some cases, preventing cancer altogether. Yet despite well-established…
🎗️
Онкология
FDA одобрило испытание новой CAR-T терапии при колоректальном раке на поздней стадии
FDA одобрило испытание новой CAR-T терапии при колоректальном раке на поздней стадии Life4me+
Онкология
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial
Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial nature.com
🎗️
Онкология
Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows
Botensilimab + balstilimab showed no CRC recurrences in resectable colon cancer, phase II NEST trial shows cancerletter.com
Онкология
Breast, cervical and colorectal cancer screening rates significantly lower for millions of U.S. adults with disabilities
Missing routine cancer screening tests can lead to critical delays in diagnosis and treatment. A new study by researchers at the American Cancer Society (ACS) shows that millions of U.S. adults with disabilities who are eligible for breast, cervical and colorectal cancer screening have lower testing rates than people…
Онкология
В Подмосковье почти на 10% выросла выявляемость колоректального рака
В Подмосковье почти на 10% выросла выявляемость колоректального рака Radio1.ru
Онкология
В Подмосковье почти на 10% выросла выявляемость колоректального рака
В Подмосковье почти на 10% выросла выявляемость колоректального рака Radio1.ru
Онкология
Blood-based CRC screening assay detects 81% of advanced adenomas
Researchers have developed a blood-based assay that could help identify individuals with precursor lesions for colorectal cancer, a known limitation of many blood-based screening tests. The assay, known as DENEB, detected 81% of advanced adenomas, as well as 91% of CRC overall and 92% of stage I to III cancers…
:og(360tv.ru,%27%D0%92%D1%8B%D1%8F%D0%B2%D0%BB%D1%8F%D0%B5%D0%BC%D0%BE%D1%81%D1%82%D1%8C%20%D0%BA%D0%BE%D0%BB%D0%BE%D1%80%D0%B5%D0%BA%D1%82%D0%B0%D0%BB%D1%8C%D0%BD%D0%BE%D0%B3%D0%BE%20%D1%80%D0%B0%D0%BA%D0%B0%20%D0%B2%C2%A0%D0%9F%D0%BE%D0%B4%D0%BC%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D1%8C%D0%B5%20%D0%B2%D1%8B%D1%80%D0%BE%D1%81%D0%BB%D0%B0%20%D0%BD%D0%B0%C2%A09,7%25%27):format(jpg)/aHR0cHM6Ly90ZXJtaW5hbC5tb3NyZWcucnUvbWVkaWEvbWVkaWEvaW1hZ2UvMjAyNi85L3Bob3RvLTIwMjYtMDktMTEtMTItNDYtMDEuanBn.jpg)
Онкология
Выявляемость колоректального рака в Подмосковье выросла на 9,7%
Выявляемость колоректального рака в Подмосковье выросла на 9,7% 360.ru
🎗️
Онкология
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer University of Colorado Anschutz